Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Saturday, June 13, 2015 10:13:50 PM
bullish
## source: finance.yahoo.com
Fri, 12 Jun 2015 12:00:00 GMT ~ Xencor to Host R&D Day and Webcast on June 26, 2015
[PR Newswire] - MONROVIA, Calif., June 12, 2015 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, ...
read full: http://finance.yahoo.com/news/xencor-host-r-d-day-120000081.html
*********************************************************
Thu, 11 Jun 2015 20:17:48 GMT ~ XENCOR INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
read full: http://biz.yahoo.com/e/150611/xncr8-k.html
*********************************************************
Wed, 10 Jun 2015 12:32:02 GMT ~ Xencor Reports Complete Data Results on XmAb5871 Program at European League Against Rheumatism (EULAR) 2015 Annual Meeting
[at noodls] - MONROVIA, Calif., June 10, 2015 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, ...
read full: http://www.noodls.com/view/AA266D2A7FC4D8DB24C959D4C795C13E54201814
*********************************************************
Wed, 10 Jun 2015 12:01:19 GMT ~ XENCOR INC Files SEC form 8-K, Other Events
read full: http://biz.yahoo.com/e/150610/xncr8-k.html
*********************************************************
Wed, 10 Jun 2015 12:00:00 GMT ~ Xencor Reports Complete Data Results on XmAb5871 Program at European League Against Rheumatism (EULAR) 2015 Annual Meeting
[PR Newswire] - MONROVIA, Calif., June 10, 2015 /PRNewswire/ -- Xencor, Inc. (XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today reported complete data results from a Phase 1b/2a study of XmAb®5871 in patients with rheumatoid arthritis (RA). XmAb5871 was generally well tolerated and showed trends in improvement in RA disease activity by multiple disease activity measures and across multiple dose groups. "These data demonstrate clear signs of disease modifying activity in a patient population with active disease while on non-biologic disease modifying anti-rheumatic drug (DMARD) therapy," said Bassil Dahiyat, Ph.D., president and chief executive officer of Xencor.
read full: http://finance.yahoo.com/news/xencor-reports-complete-data-results-120000838.html
*********************************************************
$XNCR charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$XNCR company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/XNCR/company-info
Ticker: $XNCR
OTC Market Place: Not Available
CIK code: not found
Company name: Xencor, Inc.
Incorporated In:
$XNCR share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$XNCR extra dd links
Company name: Xencor, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=XNCR+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=XNCR+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=XNCR+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/XNCR/news - http://finance.yahoo.com/q/h?s=XNCR+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/XNCR/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/XNCR/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=XNCR+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/XNCR
DTCC (dtcc.com): http://search2.dtcc.com/?q=Xencor%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Xencor%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Xencor%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/XNCR
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/XNCR/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/XNCR/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=XNCR&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=XNCR
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/XNCR/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=XNCR+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=XNCR+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=XNCR
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=XNCR
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=XNCR+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/XNCR/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=XNCR+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/XNCR.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=XNCR
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/XNCR/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/XNCR/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/XNCR
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/XNCR
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/XNCR:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=XNCR
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=XNCR
$XNCR DD Notes ~ http://www.ddnotesmaker.com/XNCR
Recent XNCR News
- Xencor Appoints Bart Cornelissen as Chief Financial Officer • Business Wire • 04/09/2024 12:01:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2024 07:47:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2024 07:45:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2024 07:40:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2024 07:40:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:10:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:09:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:07:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:05:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:03:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:01:52 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 07:39:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 01:32:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 09:48:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 09:34:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 09:27:41 PM
- Xencor to Present at Upcoming Investor Conferences • Business Wire • 02/28/2024 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:05:36 PM
- Xencor Reports Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 02/27/2024 09:01:00 PM
- Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical Update • Business Wire • 02/20/2024 09:31:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/16/2024 10:43:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:06:03 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 11:54:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 07:23:30 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/13/2024 09:07:04 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM